Zobrazeno 1 - 10
of 125
pro vyhledávání: '"BERNARD A. SCHWETZ"'
Autor:
Miriam Sander, Tom L. Beauchamp, Bernard A. Schwetz, Steven G. Gilbert, Merrill Goozner, Jacques P.J. Maurissen, Craig S. Barrow, Shelley Johnson
Publikováno v:
Toxicological Sciences. 87:11-14
There is no doubt that participants in the Conflict of Interest (COI) Workshop at the Society of Toxicology (SOT) 2005 Annual Meeting (New Orleans, 6-10 March 2005) engaged in a vigorous and useful exchange of diverse ideas and viewpoints. While ther
Autor:
William Slikker, Bernard A. Schwetz
Publikováno v:
Journal of Children's Health. 1:29-40
In industrialized countries, overweight and obesity are the most common nutritional disorders, showing an increasing prevalence. Overweight children have a high risk for being overweight in adulthood, and therefore are at risk for the disease states
Autor:
Bernard A. Schwetz, Adrian S. Dobs
Publikováno v:
Journal of Investigative Medicine. 50:356-360
Recently, researchers have witnessed a vast change regarding the protection of research participants in the clinical research environment. Although federal regulations (particularly the “Common Rule”1) governing human participant research have no
Autor:
Bernard A. Schwetz
Publikováno v:
Journal of AOAC INTERNATIONAL. 84:171-175
Autor:
Bernard A. Schwetz
Publikováno v:
International Journal of Toxicology. 20:3-8
Dr. Schwetz is the Acting Deputy Commissioner of the Food and Drug Administration (FDA). He was Director of FDA National Center for Toxicological Research in Jefferson, AR, from 1993 to 1999. A diplomate of the American Board of Toxicology, Dr. Schwe
Autor:
Brian G. Lake, John G. DeLuca, Walter Wahli, Daniel S. Marsman, Timothy A. Pastoor, Penelope A. Fenner-Crisp, Russell C. Cattley, Jonathan Tugwood, Bernard A. Schwetz, Cliff Elcombe, Denise Robinson, James A. Popp
Publikováno v:
Regulatory Toxicology and Pharmacology. 27:47-60
The purpose of the workshop "Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?" was to provide a review of the current state of the science on the relationship between peroxisome proliferation and hepatocarcinogenesis.
Autor:
Bernard A. Schwetz, William S. Stokes, Mostafa K. Mohamed, Raymond W. Tennant, Maged Younes, Martin D. Barratt, Silvia Casati, Bas J. Blaauboer, Michael Balls, Kirk R. Smith, Sandra Coecke, Jack Moore, David P. Rall
Publikováno v:
Environmental Health Perspectives
Substantial world-wide resources are being committed to develop improved toxicological testing methods that will contribute to better protection of human health and the environment. The development of new methods is intrinsically driven by new knowle
Autor:
Christina B. Myers, Julia D. George, Bernard A. Schwetz, Catherine J. Price, Jerrold J. Heindel, Melissa C. Marr
Publikováno v:
Toxicological Sciences. 46:124-133
Timed-pregnant CD-1 outbred albino Swiss mice received either methacrylamide (MAC; 0, 60, 120, or 180 mg/kg/day) or N,N'-methylenebisacrylamide (BAC; 0, 3, 10, or 30 mg/kg/day) p.o. in distilled water on gestational days (GD) 6 through 17. Maternal c
Autor:
K.L. Hulebak, Ronald P. Brown, J.A. Cavagnaro, Margaret A. Miller, J.A. Axelrad, Ronald J. Lorentzen, Bernard A. Schwetz, David W. Gaylor, W.H. Cyr, L.T. Mulligan
Publikováno v:
Regulatory Toxicology and Pharmacology. 26:307-321
The U.S. Food and Drug Administration (FDA) regulates a wide variety of consumer products. Safety issues involve chemical and microbial contaminants in food, biologics, and medical devices; side effects from prescription and nonprescription drugs; re
Autor:
David W. Gaylor, Bernard A. Schwetz
Publikováno v:
Molecular Carcinogenesis. 20:275-279
Carcinogenicity testing today normally includes conducting 2-yr studies of rats and mice of both sexes and following widely accepted procedures for husbandry, selection of dose levels, pathology and toxicity observations, and statistical interpretati